Medications for Metabolic Bone Disease

Vitamin D is a regulator of calcium homeostasis in the body and is important in skeletal development and bone mineralization. Patients with chronic kidney disease can have significant abnormalities of bone and calcium homeostasis and are at increased risk of fracture. The fracture risk for a kidney transplant recipient is four times that of the general population and higher than that for a patient on dialysis.Blood phosphorus and calcium levels can be altered by a hormone called parathyroid hormone (PTH). In chronic kidney disease, PTH production can increase to result in abnormalities of calcium and phosphorus in the blood as well as bone and cardiovascular side effects 

 

Drug

Dosage Regimen

Contraindications

Side Effects

Drug Interactions

Doxercalciferol
(Hectoral®)

Oral:1 to 3 mcg per day in patients not yet on dialysis or 10 to 20 mcg 3 times/week at dialysis; dose adjusted at 8-week intervals based upon the iPTH levels.

High blood calcium; Vitamin D toxicity; high blood phosphorus

Nausea, vomiting, increase in urine volume, headache, dizziness, constipation

Cholestyramine, mineral oil-Reduced absorption of doxercalciferol
Other Vitamin D supplements – increased risk of vitamin D intoxication, magnesium containing antacids and supplements-Increase the risk of high blood magnesium levels
Ketoconazole, erythromycin – decreased conversion of doxercalciferol to active drug
Phenobarbital – may need higher doses of doxercalciferol

Calcitriol
(Rocaltrol®; Calcijex™)

Oral: 0.25-2 mcg/day or every other day; increases should be made at 4 to 8 week intervals
IV: 0.5 mcg/day 3 times/week if undergoing hemodialysis

High blood calcium; vitamin D intoxication, malabsorption syndrome; allergic reaction

High blood calcium, constipation, headache, high or low blood pressure, increased production of urine volume, seizures

Decreased effect/absorption: Cholestyramine, colestipol
Increased effect: Thiazide diuretics
Additive effect: Magnesium-containing antacids

Paricalcitol
(Zemplar™)

Oral: 1 to 2 mcg daily or 2 to 4 mcg three times weekly

IV: 0.04-0.1 mcg/kg given 3 times weekly during dialysis

Vitamin D toxicity; high blood calcium; hypersensitivity to any component of the drug

Nausea, vomiting, swelling, chills, fever, lightheadedness

Vitamin D-increased risk of vitamin D intoxication; related drugs should not be taken while taking this drug.
Ketoconazole, clarithromycin, nefazodone, ritonavir and related drugs – increased risk of paricalcitol toxicity